Simulations Plus Corp (SLP) - Projected Sales Volume

Simulations Plus, Inc. (SLP) relies on a niche profile of IT solutions for pharmacology, which is offset by stable subscription revenue from global clients. The operating model is based on a partner sales network and cloud hosting. The company's future sales trajectory on this chart demonstrates the potential of a drug modeling leader, where 0.08 expresses a fresh metric level, confirming GastroPlus's status as an industry benchmark.

Company Expected Sales Volume: Simulations Plus, Inc. (SLP) for 07/04/2022 - 10/18/2026

Analytical breakdowns and data insights for company Simulations Plus Inc (SLP)

- current price and projected stock value:

Stock Quotes Simulations Plus, Inc.|SLP - Analyst Forecast Prices

- market capitalization indicators:

Market Capitalization Simulations Plus Inc|SLP - Company Buyout Price

- book capitalization information:

Net Assets per Single Share Simulations Plus|SLP - Total Stockholders' Equity|Market Value to Book Value Ratio simulations-plus.com|SLP - Total Business Assets

- debt and liquidity details:

Debt to Equity Simulations Plus, Inc.|SLP - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio Simulations Plus Corp|SLP - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Simulations Plus Inc|SLP - Long-Term Liabilities|Company Short-Term Debt Simulations Plus|Quick Liquidity Indicator simulations-plus.com

- company profitability and valuation multiples indicators:

SLP - Net Profit|Expected Profit Simulations Plus, Inc.|SLP - Business Payback Period|Projected Price to Earnings Simulations Plus|SLP - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Simulations Plus Inc|SLP - Operating income before deduction of amortization|Earnings per share for the last twelve months Simulations Plus|SLP - Earnings per share for the last 12 months|Quarterly EPS earnings growth simulations-plus.com|SLP - Net earnings per share growth this year|Expected earnings per share growth for next year Simulations Plus, Inc.

- sales and revenue data:

SLP - Company Gross Revenue|Company Projected Revenue Simulations Plus, Inc.|SLP - Price-to-Revenue Coefficient|Price-to-Projected Revenue Ratio Simulations Plus Inc

Fundamental valuation:SLP Simulations Plus, Inc.

Signature product of Simulations Plus Inc.

Simulations Plus, Inc. (SLP) is transforming pharmaceuticals by replacing costly clinical trials with digital simulation, which is directly reflected in the trend of projected sales revenue. This metric assesses capital density by comparing market quotes with management's commercial goals, allowing investors to identify the gap between actual cash inflows and declared reporting to evaluate the asset's fundamental stability.

Competitor analysis for Simulations Plus, Inc.